跳至主要内容
临床试验/EUCTR2005-001587-31-SE
EUCTR2005-001587-31-SE进行中(未招募)不适用

/A - Safety and initial pain relieving effect of 2PX, a topical formulation.

SantoSolve AS0 个研究点开始时间: 2005年4月19日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Diagnosed fibromyalgia
  • Stable symptom duration for at least 1 year
  • Age 18-65 years
  • Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Inflammatory reumatoid disease
  • Skin disorders
  • Established diagnosis of psoriasis
  • Established diagnosis of depression
  • Evident of any concomitant systemic disease or major surgery
  • Chronic treatment with opioids, NSAID's or other pain relieving drugs

研究者

发起方
SantoSolve AS

相似试验